Integra
-
Extremities
Integra LifeSciences Receives FDA Approval of Integra® Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU)
PLAINSBORO, N.J., Jan. 07, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that the United States Food and Drug…
Read More » -
Financial
Integra to Complete Tax-Free Spin-Off of SeaSpine on July 1, 2015
PLAINSBORO, N.J., June 9, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Board of Directors of Integra…
Read More » -
Hospitals
Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine
PLAINSBORO, N.J., April 1, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the filing of an initial Form 10…
Read More » -
Biologics
Integra LifeSciences Announces Submission of a Premarket Approval Supplement Application for the Treatment of Diabetic Foot Ulcers
PLAINSBORO, N.J., Feb. 3, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced it has completed the submission…
Read More » -
Extremities
Integra LifeSciences Acquires Metasurg’s Foot and Ankle Product Portfolio
PLAINSBORO, N.J., Jan. 12, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, in December, it closed…
Read More » -
Biologics
Integra LifeSciences Launches Integra(R) Reinforcement Matrix
PLAINSBORO, N.J., Jan. 21, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full market release of…
Read More » -
Spine
Integra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery
PLAINSBORO, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the controlled market release of…
Read More » -
Spine
SeaSpine is Back! Integra to spin out spine biz
November 3, 2014 by Brad Perriello Integra LifeSciences says it plans to spin out its spine business as a stand-alone…
Read More » -
Biologics
Integra Gets Thumbs Up on FDA Reinspection of Puerto Rico Plant
The FDA completed its reinspection of Integra Life Sciences’ Añasco, Puerto Rico, manufacturing facility on Sept. 30, finding all issues…
Read More » -
Biologics
Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business
PLAINSBORO, N.J., Sept. 2, 2014 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has made changes to the…
Read More » -
Integra Lifesciences Expresses Interest to Divest Spine Business
BY ANDREW VAHRADIAN, AUGUST 27, 2014 Last week, Glenn Coleman the CFO of Integra Lifesciences, expressed to analysts that the…
Read More » -
Spine
Former Integra sales rep, manager admit to $800k hospital fraud scheme
TRENTON, N.J. – A regional manager and a product specialist selling medical devices to hospitals for Integra LifeSciences Corp. of…
Read More » -
Financial
Integra LifeSciences Reports Second Quarter 2014 Financial Results
Revenue Increased 12.6% to a Record of $231 million Adjusted Diluted EPS Increased by 28% Free Cash Flow Increased by…
Read More » -
Integra LifeSciences Announces Renewal and Extension of Credit Facility
PLAINSBORO, N.J., July 9, 2014 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has established new terms under…
Read More » -
Integra LifeSciences, Premier Ink 3-Year Purchase Deal
The Orthopedics and Tissue Technologies group of Integra LifeSciences Holding Corporation (IART – Snapshot Report) has recently signed a 3-year group purchasing contract with…
Read More »